Dr. Reddy’s, Marc Kikuchi
Dr. Reddy’s brought in Marc Kikuchi as CEO of its North America Generics division. The region is a particularly important sector for the business, with more than half of revenue from global sales of generics generated in the region, according to 2017/2018 financial figures – while global sales of generics make up 80% of the net revenue for the overall business.
Kikuchi arrives at the company having already accrued a number of years’ experience of the generics market in North America. He worked as CEO for the Americas at Zydus Pharmaceuticals for two years and worked at AmerisourceBergen for 11 years, holding the role of SVP of global generics during this time.